Page last updated: 2024-08-21

isoxazoles and Pulmonary Sarcoidosis

isoxazoles has been researched along with Pulmonary Sarcoidosis in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	3 (75.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aronson, IK; Au, S; Mirsaeidi, M; Sweiss, NJ	1
Bandyopadhyay, D; Chapman, JT; Culver, DA; Lazar, CA; Parambil, JG; Pearson, K; Sahoo, DH; Xu, M	1
Baughman, RP; Lower, EE; Nunes, H; Sweiss, NJ	1
Chida, K; Miyazaki, K; Ogura, T; Sugiyama, Y; Yamaguchi, T	1

Reviews

1 review(s) available for isoxazoles and Pulmonary Sarcoidosis

Article	Year
Established and experimental medical therapy of pulmonary sarcoidosis. The European respiratory journal, 2013, Volume: 41, Issue:6 Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Clinical Trials as Topic; Dyspnea; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Positron-Emission Tomography; Quality of Life; Radiography, Thoracic; Research Design; Respiratory Function Tests; Sarcoidosis, Pulmonary; Therapies, Investigational; Treatment Outcome	2013

Article

Year

Established and experimental medical therapy of pulmonary sarcoidosis.

The European respiratory journal, 2013, Volume: 41, Issue:6

Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Clinical Trials as Topic; Dyspnea; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Isoxazoles; Leflunomide; Methotrexate; Positron-Emission Tomography; Quality of Life; Radiography, Thoracic; Research Design; Respiratory Function Tests; Sarcoidosis, Pulmonary; Therapies, Investigational; Treatment Outcome

2013

Other Studies

3 other study(ies) available for isoxazoles and Pulmonary Sarcoidosis

Article	Year
Adalimumab Induced Subcutaneous Nodular Sarcoidosis; A Rare Side Effect of Tumor Necrosis Factor-α Inhibitor. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2014, Oct-20, Volume: 31, Issue:3 Topics: Adalimumab; Biopsy; Female; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Middle Aged; Remission Induction; Sarcoidosis; Sarcoidosis, Pulmonary; Subcutaneous Tissue; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha	2014
Effectiveness and safety of leflunomide for pulmonary and extrapulmonary sarcoidosis. The European respiratory journal, 2011, Volume: 38, Issue:5 Topics: Adjuvants, Immunologic; Female; Humans; Isoxazoles; Leflunomide; Male; Middle Aged; Sarcoidosis; Sarcoidosis, Pulmonary	2011
[Diagnosis of and therapy for diffuse lung diseases (discussion)]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2006, Jun-10, Volume: 95, Issue:6 Topics: Alveolitis, Extrinsic Allergic; Biomarkers; Bronchiolitis; Gefitinib; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Quinazolines; Sarcoidosis, Pulmonary; Tomography, X-Ray Computed	2006